Age of the company
8 yearsCapital in CHF
106'200Active brands
0Reports for Gliapharm SA
Credit rating information
Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company. Find out moreEconomic information
Comprehensive information about the economic situation of a company. Find out morePayment collection information
Overview of current and past debt enforcement proceedings. Find out moreCompany dossier as PDF
Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data. Retrieve company dossierAbout Gliapharm SA
- Gliapharm SA is currently active and the industry «Research and development». The legal headquarters are in Genève.
- The management of the company Gliapharm SA consists of 4 persons.
- The last commercial register change was made on 05.08.2022. All changes can be viewed under the section «Notifications» and saved as a PDF.
- The company Gliapharm SA is registered under the UID CHE-193.477.382.
- There are 11 other active companies that have registered an identical address. These include: EBRAINS, Bruxelles, succursale de Genève, FONDATION AGALMA, Fondation Campus Biotech Geneva.
Management (4)
newest board members
Sylvain Lengacher,
Prof. Dr. Pierre Julius Magistretti,
Ambroise Charles Diego Magistretti,
Charles Finsterwald
newest authorized signatories
Sylvain Lengacher,
Prof. Dr. Pierre Julius Magistretti,
Ambroise Charles Diego Magistretti,
Charles Finsterwald
Commercial register information
Entry in the commercial register
08.04.2016
Legal form
Company limited by shares (AG)
Legal headquarters of the company
Genève
Commercial Registry Office
GE
Commercial register number
CH-550.1.166.424-0
UID/VAT
CHE-193.477.382
Sector
Research and development
Purpose (Original language) Customise the company purpose with just a few clicks.
La Société a pour but la recherche, le développement et la commercialisation de substances pharmaceutiques visant à traiter les maladies neurologiques (pour but complet cf. statuts).
Auditor
Current auditor (1)
Name | City | Since | Until | |
---|---|---|---|---|
PricewaterhouseCoopers SA | Genève | 05.08.2022 |
Other company names
Past and translated company names
- Gliapharm AG
- Gliapharm Ltd
Ownership structure
Holdings
Newest SOGC notifications: Gliapharm SA
The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications
Publication number: HR02-1005536180, Commercial Registry Office Geneva, (660)
Gliapharm SA, à Genève, CHE-193.477.382 (FOSC du 31.05.2019, p. 0/1004642292). Par décision du 30.06.2022, l'assemblée générale a modifié la clause statutaire introduite le 26.07.2016 en matière d'augmentation conditionnelle du capital-participation;
pour les détails voir les statuts. Création d'un capital-participation, fondée sur la clause statutaire relative à la création d'un capital-participation conditionnel, introduite par l'assemblée générale du 26.07.2016 et modifiée le 30.06.2022, d'un montant de CHF 6'200, par l'émission de 6'200 bons de participation de CHF 1 chacun, nominatifs, liés selon les statuts.
Capital-participation:
CHF 6'200, entièrement libéré, divisé en 6'200 bons de CHF 1, nominatifs, liés selon statuts. Statuts modifiés le 30.06.2022. Finsterwald Charles est maintenant domicilié à Crassier.
Organe de révision:
PricewaterhouseCoopers SA (CHE-390.062.0059), à Genève. Radiation de la mention de renonciation au contrôle restreint.
Publication number: HR02-1004642292, Commercial Registry Office Geneva, (660)
Gliapharm SA, à Genève, CHE-193.477.382 (FOSC du 19.12.2017, p. 0/3942039). Le capital-actions de CHF 100'000 a été libéré ultérieurement à concurrence de CHF 50'000.
Capital-actions:
CHF 100'000, entièrement libéré, divisé en 100'000 actions des CHF 1, nominatives, liées selon statuts. Statuts modifiés le 23.05.2019. Finsterwald Charles et Magistretti Ambroise sont maintenant domiciliés, respectivement, à Veyrier et à Pully.
Publication number: 3941787, Commercial Registry Office Vaud, (550)
Gliapharm SA, Lausanne, CHE-193.477.382 (FOSC du 08.08.2016, p. 0/2993165). La société ayant transféré son siège à Genève, la raison de commerce est radiée d'office du Registre du commerce du canton de Vaud.
Hit list
Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.